nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—endothelium—hypertension	0.0238	0.141	CbGeAlD
Framycetin—CXCR4—blood vessel—hypertension	0.0219	0.13	CbGeAlD
Framycetin—CXCR4—myocardium—hypertension	0.0149	0.0882	CbGeAlD
Framycetin—CXCR4—adrenal cortex—hypertension	0.0107	0.0637	CbGeAlD
Framycetin—CXCR4—heart—hypertension	0.0104	0.0616	CbGeAlD
Framycetin—CXCR4—smooth muscle tissue—hypertension	0.0103	0.0611	CbGeAlD
Framycetin—CXCR4—decidua—hypertension	0.0101	0.0599	CbGeAlD
Framycetin—CXCR4—cardiovascular system—hypertension	0.00979	0.0581	CbGeAlD
Framycetin—CXCR4—kidney—hypertension	0.00957	0.0568	CbGeAlD
Framycetin—CXCR4—cortex of kidney—hypertension	0.00932	0.0554	CbGeAlD
Framycetin—CXCR4—cardiac atrium—hypertension	0.00887	0.0527	CbGeAlD
Framycetin—CXCR4—medulla oblongata—hypertension	0.00836	0.0496	CbGeAlD
Framycetin—CXCR4—adrenal gland—hypertension	0.00774	0.0459	CbGeAlD
Framycetin—CXCR4—endocrine gland—hypertension	0.00671	0.0398	CbGeAlD
Framycetin—CXCR4—central nervous system—hypertension	0.00605	0.0359	CbGeAlD
Framycetin—Anaphylactic shock—Indapamide—hypertension	0.000848	0.00251	CcSEcCtD
Framycetin—Infection—Diltiazem—hypertension	0.000843	0.0025	CcSEcCtD
Framycetin—Infection—Indapamide—hypertension	0.000843	0.0025	CcSEcCtD
Framycetin—Anaphylactic shock—Carvedilol—hypertension	0.00084	0.00249	CcSEcCtD
Framycetin—Erythema—Telmisartan—hypertension	0.00084	0.00249	CcSEcCtD
Framycetin—Diarrhoea—Quinapril—hypertension	0.000838	0.00248	CcSEcCtD
Framycetin—Pruritus—Isradipine—hypertension	0.000836	0.00248	CcSEcCtD
Framycetin—Infection—Carvedilol—hypertension	0.000835	0.00247	CcSEcCtD
Framycetin—Pruritus—Guanfacine—hypertension	0.000833	0.00247	CcSEcCtD
Framycetin—Vomiting—Candesartan—hypertension	0.000829	0.00246	CcSEcCtD
Framycetin—Infection—Doxazosin—hypertension	0.000825	0.00245	CcSEcCtD
Framycetin—Diarrhoea—Benazepril—hypertension	0.000825	0.00244	CcSEcCtD
Framycetin—Hypersensitivity—Terazosin—hypertension	0.000823	0.00244	CcSEcCtD
Framycetin—Diarrhoea—Nadolol—hypertension	0.000821	0.00243	CcSEcCtD
Framycetin—Pruritus—Metolazone—hypertension	0.000821	0.00243	CcSEcCtD
Framycetin—Pruritus—Felodipine—hypertension	0.000821	0.00243	CcSEcCtD
Framycetin—Anaphylactic shock—Fosinopril—hypertension	0.000821	0.00243	CcSEcCtD
Framycetin—Pruritus—Spironolactone—hypertension	0.000818	0.00243	CcSEcCtD
Framycetin—Vomiting—Methyldopa—hypertension	0.000817	0.00242	CcSEcCtD
Framycetin—Infection—Fosinopril—hypertension	0.000815	0.00242	CcSEcCtD
Framycetin—Infection—Eplerenone—hypertension	0.00081	0.0024	CcSEcCtD
Framycetin—Anaphylactic shock—Nifedipine—hypertension	0.00081	0.0024	CcSEcCtD
Framycetin—Diarrhoea—Isradipine—hypertension	0.000809	0.0024	CcSEcCtD
Framycetin—Anaphylactic shock—Verapamil—hypertension	0.000806	0.00239	CcSEcCtD
Framycetin—Diarrhoea—Guanfacine—hypertension	0.000806	0.00239	CcSEcCtD
Framycetin—Diarrhoea—Nicardipine—hypertension	0.000803	0.00238	CcSEcCtD
Framycetin—Vomiting—Hydralazine—hypertension	0.000802	0.00238	CcSEcCtD
Framycetin—Vomiting—Amiloride—hypertension	0.000802	0.00238	CcSEcCtD
Framycetin—Nausea—Bepridil—hypertension	0.000802	0.00238	CcSEcCtD
Framycetin—Pruritus—Esmolol—hypertension	0.000801	0.00238	CcSEcCtD
Framycetin—Infection—Verapamil—hypertension	0.000801	0.00237	CcSEcCtD
Framycetin—Hypersensitivity—Labetalol—hypertension	0.000795	0.00236	CcSEcCtD
Framycetin—Diarrhoea—Felodipine—hypertension	0.000794	0.00235	CcSEcCtD
Framycetin—Diarrhoea—Metolazone—hypertension	0.000794	0.00235	CcSEcCtD
Framycetin—Nausea—Penbutolol—hypertension	0.000794	0.00235	CcSEcCtD
Framycetin—Erythema—Perindopril—hypertension	0.000793	0.00235	CcSEcCtD
Framycetin—Vomiting—Pindolol—hypertension	0.000792	0.00235	CcSEcCtD
Framycetin—Diarrhoea—Spironolactone—hypertension	0.000791	0.00235	CcSEcCtD
Framycetin—Pruritus—Terazosin—hypertension	0.000791	0.00234	CcSEcCtD
Framycetin—Erythema—Irbesartan—hypertension	0.00079	0.00234	CcSEcCtD
Framycetin—Erythema—Hydrochlorothiazide—hypertension	0.000784	0.00232	CcSEcCtD
Framycetin—Vomiting—Quinapril—hypertension	0.000779	0.00231	CcSEcCtD
Framycetin—Nausea—Candesartan—hypertension	0.000774	0.0023	CcSEcCtD
Framycetin—Erythema—Furosemide—hypertension	0.000771	0.00229	CcSEcCtD
Framycetin—Pruritus—Acebutolol—hypertension	0.000771	0.00229	CcSEcCtD
Framycetin—Hypersensitivity—Eprosartan—hypertension	0.000771	0.00228	CcSEcCtD
Framycetin—Vomiting—Benazepril—hypertension	0.000766	0.00227	CcSEcCtD
Framycetin—Diarrhoea—Terazosin—hypertension	0.000765	0.00227	CcSEcCtD
Framycetin—Pruritus—Labetalol—hypertension	0.000764	0.00226	CcSEcCtD
Framycetin—Nausea—Methyldopa—hypertension	0.000763	0.00226	CcSEcCtD
Framycetin—Vomiting—Nadolol—hypertension	0.000763	0.00226	CcSEcCtD
Framycetin—Erythema—Betaxolol—hypertension	0.000763	0.00226	CcSEcCtD
Framycetin—Vomiting—Isradipine—hypertension	0.000752	0.00223	CcSEcCtD
Framycetin—Anaphylactic shock—Valsartan—hypertension	0.000751	0.00223	CcSEcCtD
Framycetin—Nausea—Amiloride—hypertension	0.00075	0.00222	CcSEcCtD
Framycetin—Nausea—Hydralazine—hypertension	0.00075	0.00222	CcSEcCtD
Framycetin—Vomiting—Guanfacine—hypertension	0.000749	0.00222	CcSEcCtD
Framycetin—Hypersensitivity—Nisoldipine—hypertension	0.000748	0.00222	CcSEcCtD
Framycetin—Hypersensitivity—Amlodipine—hypertension	0.000748	0.00222	CcSEcCtD
Framycetin—Anaphylactic shock—Olmesartan—hypertension	0.000747	0.00221	CcSEcCtD
Framycetin—Vomiting—Nicardipine—hypertension	0.000746	0.00221	CcSEcCtD
Framycetin—Infection—Valsartan—hypertension	0.000746	0.00221	CcSEcCtD
Framycetin—Diarrhoea—Acebutolol—hypertension	0.000745	0.00221	CcSEcCtD
Framycetin—Erythema—Losartan—hypertension	0.000744	0.0022	CcSEcCtD
Framycetin—Infection—Olmesartan—hypertension	0.000742	0.0022	CcSEcCtD
Framycetin—Nausea—Pindolol—hypertension	0.00074	0.00219	CcSEcCtD
Framycetin—Pruritus—Eprosartan—hypertension	0.00074	0.00219	CcSEcCtD
Framycetin—Diarrhoea—Labetalol—hypertension	0.000739	0.00219	CcSEcCtD
Framycetin—Vomiting—Felodipine—hypertension	0.000738	0.00219	CcSEcCtD
Framycetin—Vomiting—Metolazone—hypertension	0.000738	0.00219	CcSEcCtD
Framycetin—Vomiting—Spironolactone—hypertension	0.000735	0.00218	CcSEcCtD
Framycetin—Nausea—Quinapril—hypertension	0.000728	0.00216	CcSEcCtD
Framycetin—Vomiting—Esmolol—hypertension	0.00072	0.00213	CcSEcCtD
Framycetin—Pruritus—Nisoldipine—hypertension	0.000718	0.00213	CcSEcCtD
Framycetin—Pruritus—Amlodipine—hypertension	0.000718	0.00213	CcSEcCtD
Framycetin—Nausea—Benazepril—hypertension	0.000716	0.00212	CcSEcCtD
Framycetin—Diarrhoea—Eprosartan—hypertension	0.000716	0.00212	CcSEcCtD
Framycetin—Nausea—Nadolol—hypertension	0.000713	0.00211	CcSEcCtD
Framycetin—Infection—Clonidine—hypertension	0.000711	0.00211	CcSEcCtD
Framycetin—Vomiting—Terazosin—hypertension	0.000711	0.00211	CcSEcCtD
Framycetin—Hypersensitivity—Guanabenz—hypertension	0.000703	0.00208	CcSEcCtD
Framycetin—Hypersensitivity—Metoprolol—hypertension	0.000703	0.00208	CcSEcCtD
Framycetin—Nausea—Isradipine—hypertension	0.000702	0.00208	CcSEcCtD
Framycetin—Nausea—Guanfacine—hypertension	0.0007	0.00207	CcSEcCtD
Framycetin—Nausea—Nicardipine—hypertension	0.000697	0.00207	CcSEcCtD
Framycetin—Anaphylactic shock—Enalapril—hypertension	0.000695	0.00206	CcSEcCtD
Framycetin—Diarrhoea—Amlodipine—hypertension	0.000695	0.00206	CcSEcCtD
Framycetin—Diarrhoea—Nisoldipine—hypertension	0.000695	0.00206	CcSEcCtD
Framycetin—Infection—Trandolapril—hypertension	0.000693	0.00206	CcSEcCtD
Framycetin—Vomiting—Acebutolol—hypertension	0.000693	0.00205	CcSEcCtD
Framycetin—Nausea—Felodipine—hypertension	0.000689	0.00204	CcSEcCtD
Framycetin—Nausea—Metolazone—hypertension	0.000689	0.00204	CcSEcCtD
Framycetin—Nausea—Spironolactone—hypertension	0.000687	0.00204	CcSEcCtD
Framycetin—Vomiting—Labetalol—hypertension	0.000686	0.00203	CcSEcCtD
Framycetin—Anaphylactic shock—Telmisartan—hypertension	0.000686	0.00203	CcSEcCtD
Framycetin—Infection—Telmisartan—hypertension	0.000681	0.00202	CcSEcCtD
Framycetin—Pruritus—Guanabenz—hypertension	0.000675	0.002	CcSEcCtD
Framycetin—Pruritus—Metoprolol—hypertension	0.000675	0.002	CcSEcCtD
Framycetin—Nausea—Esmolol—hypertension	0.000673	0.00199	CcSEcCtD
Framycetin—Anaphylactic shock—Captopril—hypertension	0.000667	0.00198	CcSEcCtD
Framycetin—Vomiting—Eprosartan—hypertension	0.000665	0.00197	CcSEcCtD
Framycetin—Nausea—Terazosin—hypertension	0.000664	0.00197	CcSEcCtD
Framycetin—Diarrhoea—Metoprolol—hypertension	0.000653	0.00194	CcSEcCtD
Framycetin—Diarrhoea—Guanabenz—hypertension	0.000653	0.00194	CcSEcCtD
Framycetin—Anaphylactic shock—Perindopril—hypertension	0.000647	0.00192	CcSEcCtD
Framycetin—Nausea—Acebutolol—hypertension	0.000647	0.00192	CcSEcCtD
Framycetin—Hypersensitivity—Propranolol—hypertension	0.000646	0.00191	CcSEcCtD
Framycetin—Vomiting—Amlodipine—hypertension	0.000646	0.00191	CcSEcCtD
Framycetin—Anaphylactic shock—Irbesartan—hypertension	0.000645	0.00191	CcSEcCtD
Framycetin—Nausea—Labetalol—hypertension	0.000641	0.0019	CcSEcCtD
Framycetin—Infection—Irbesartan—hypertension	0.000641	0.0019	CcSEcCtD
Framycetin—Anaphylactic shock—Hydrochlorothiazide—hypertension	0.00064	0.0019	CcSEcCtD
Framycetin—Erythema—Ramipril—hypertension	0.000638	0.00189	CcSEcCtD
Framycetin—Anaphylactic shock—Furosemide—hypertension	0.000629	0.00187	CcSEcCtD
Framycetin—Hypersensitivity—Indapamide—hypertension	0.000625	0.00185	CcSEcCtD
Framycetin—Hypersensitivity—Diltiazem—hypertension	0.000625	0.00185	CcSEcCtD
Framycetin—Erythema—Timolol—hypertension	0.000624	0.00185	CcSEcCtD
Framycetin—Nausea—Eprosartan—hypertension	0.000621	0.00184	CcSEcCtD
Framycetin—Hypersensitivity—Carvedilol—hypertension	0.000619	0.00183	CcSEcCtD
Framycetin—Infection—Betaxolol—hypertension	0.000619	0.00183	CcSEcCtD
Framycetin—Hypersensitivity—Doxazosin—hypertension	0.000612	0.00181	CcSEcCtD
Framycetin—Anaphylactic shock—Losartan—hypertension	0.000607	0.0018	CcSEcCtD
Framycetin—Vomiting—Guanabenz—hypertension	0.000607	0.0018	CcSEcCtD
Framycetin—Vomiting—Metoprolol—hypertension	0.000607	0.0018	CcSEcCtD
Framycetin—Hypersensitivity—Fosinopril—hypertension	0.000605	0.00179	CcSEcCtD
Framycetin—Nausea—Amlodipine—hypertension	0.000603	0.00179	CcSEcCtD
Framycetin—Nausea—Nisoldipine—hypertension	0.000603	0.00179	CcSEcCtD
Framycetin—Infection—Losartan—hypertension	0.000603	0.00179	CcSEcCtD
Framycetin—Pruritus—Diltiazem—hypertension	0.0006	0.00178	CcSEcCtD
Framycetin—Pruritus—Indapamide—hypertension	0.0006	0.00178	CcSEcCtD
Framycetin—Diarrhoea—Propranolol—hypertension	0.0006	0.00178	CcSEcCtD
Framycetin—Hypersensitivity—Nifedipine—hypertension	0.000597	0.00177	CcSEcCtD
Framycetin—Pruritus—Carvedilol—hypertension	0.000594	0.00176	CcSEcCtD
Framycetin—Hypersensitivity—Verapamil—hypertension	0.000594	0.00176	CcSEcCtD
Framycetin—Pruritus—Doxazosin—hypertension	0.000588	0.00174	CcSEcCtD
Framycetin—Pruritus—Fosinopril—hypertension	0.000581	0.00172	CcSEcCtD
Framycetin—Diarrhoea—Indapamide—hypertension	0.00058	0.00172	CcSEcCtD
Framycetin—Diarrhoea—Diltiazem—hypertension	0.00058	0.00172	CcSEcCtD
Framycetin—Erythema—Lisinopril—hypertension	0.000578	0.00171	CcSEcCtD
Framycetin—Pruritus—Eplerenone—hypertension	0.000577	0.00171	CcSEcCtD
Framycetin—Diarrhoea—Carvedilol—hypertension	0.000575	0.0017	CcSEcCtD
Framycetin—Pruritus—Nifedipine—hypertension	0.000573	0.0017	CcSEcCtD
Framycetin—Pruritus—Verapamil—hypertension	0.00057	0.00169	CcSEcCtD
Framycetin—Diarrhoea—Doxazosin—hypertension	0.000568	0.00169	CcSEcCtD
Framycetin—Nausea—Metoprolol—hypertension	0.000567	0.00168	CcSEcCtD
Framycetin—Nausea—Guanabenz—hypertension	0.000567	0.00168	CcSEcCtD
Framycetin—Diarrhoea—Fosinopril—hypertension	0.000562	0.00166	CcSEcCtD
Framycetin—Diarrhoea—Eplerenone—hypertension	0.000558	0.00165	CcSEcCtD
Framycetin—Vomiting—Propranolol—hypertension	0.000557	0.00165	CcSEcCtD
Framycetin—Diarrhoea—Nifedipine—hypertension	0.000554	0.00164	CcSEcCtD
Framycetin—Hypersensitivity—Valsartan—hypertension	0.000553	0.00164	CcSEcCtD
Framycetin—Diarrhoea—Verapamil—hypertension	0.000552	0.00164	CcSEcCtD
Framycetin—Vomiting—Diltiazem—hypertension	0.000539	0.0016	CcSEcCtD
Framycetin—Vomiting—Indapamide—hypertension	0.000539	0.0016	CcSEcCtD
Framycetin—Vomiting—Carvedilol—hypertension	0.000534	0.00158	CcSEcCtD
Framycetin—Pruritus—Valsartan—hypertension	0.000531	0.00157	CcSEcCtD
Framycetin—Pruritus—Olmesartan—hypertension	0.000528	0.00157	CcSEcCtD
Framycetin—Vomiting—Doxazosin—hypertension	0.000528	0.00157	CcSEcCtD
Framycetin—Hypersensitivity—Clonidine—hypertension	0.000527	0.00156	CcSEcCtD
Framycetin—Vomiting—Fosinopril—hypertension	0.000522	0.00155	CcSEcCtD
Framycetin—Nausea—Propranolol—hypertension	0.000521	0.00154	CcSEcCtD
Framycetin—Anaphylactic shock—Ramipril—hypertension	0.000521	0.00154	CcSEcCtD
Framycetin—Vomiting—Eplerenone—hypertension	0.000519	0.00154	CcSEcCtD
Framycetin—Vomiting—Nifedipine—hypertension	0.000515	0.00153	CcSEcCtD
Framycetin—Hypersensitivity—Trandolapril—hypertension	0.000514	0.00152	CcSEcCtD
Framycetin—Diarrhoea—Valsartan—hypertension	0.000514	0.00152	CcSEcCtD
Framycetin—Vomiting—Verapamil—hypertension	0.000513	0.00152	CcSEcCtD
Framycetin—Hypersensitivity—Enalapril—hypertension	0.000512	0.00152	CcSEcCtD
Framycetin—Diarrhoea—Olmesartan—hypertension	0.000511	0.00152	CcSEcCtD
Framycetin—Anaphylactic shock—Timolol—hypertension	0.000509	0.00151	CcSEcCtD
Framycetin—Pruritus—Clonidine—hypertension	0.000506	0.0015	CcSEcCtD
Framycetin—Infection—Timolol—hypertension	0.000506	0.0015	CcSEcCtD
Framycetin—Hypersensitivity—Telmisartan—hypertension	0.000505	0.0015	CcSEcCtD
Framycetin—Nausea—Diltiazem—hypertension	0.000504	0.00149	CcSEcCtD
Framycetin—Nausea—Indapamide—hypertension	0.000504	0.00149	CcSEcCtD
Framycetin—Nausea—Carvedilol—hypertension	0.000499	0.00148	CcSEcCtD
Framycetin—Pruritus—Trandolapril—hypertension	0.000494	0.00146	CcSEcCtD
Framycetin—Nausea—Doxazosin—hypertension	0.000494	0.00146	CcSEcCtD
Framycetin—Pruritus—Enalapril—hypertension	0.000492	0.00146	CcSEcCtD
Framycetin—Diarrhoea—Clonidine—hypertension	0.00049	0.00145	CcSEcCtD
Framycetin—Nausea—Fosinopril—hypertension	0.000487	0.00145	CcSEcCtD
Framycetin—Pruritus—Telmisartan—hypertension	0.000485	0.00144	CcSEcCtD
Framycetin—Nausea—Eplerenone—hypertension	0.000485	0.00144	CcSEcCtD
Framycetin—Nausea—Nifedipine—hypertension	0.000481	0.00143	CcSEcCtD
Framycetin—Nausea—Verapamil—hypertension	0.000479	0.00142	CcSEcCtD
Framycetin—Diarrhoea—Trandolapril—hypertension	0.000477	0.00142	CcSEcCtD
Framycetin—Vomiting—Valsartan—hypertension	0.000477	0.00141	CcSEcCtD
Framycetin—Diarrhoea—Enalapril—hypertension	0.000476	0.00141	CcSEcCtD
Framycetin—Hypersensitivity—Irbesartan—hypertension	0.000475	0.00141	CcSEcCtD
Framycetin—Vomiting—Olmesartan—hypertension	0.000475	0.00141	CcSEcCtD
Framycetin—Anaphylactic shock—Lisinopril—hypertension	0.000472	0.0014	CcSEcCtD
Framycetin—Pruritus—Captopril—hypertension	0.000472	0.0014	CcSEcCtD
Framycetin—Hypersensitivity—Hydrochlorothiazide—hypertension	0.000471	0.0014	CcSEcCtD
Framycetin—Diarrhoea—Telmisartan—hypertension	0.000469	0.00139	CcSEcCtD
Framycetin—Infection—Lisinopril—hypertension	0.000469	0.00139	CcSEcCtD
Framycetin—Hypersensitivity—Furosemide—hypertension	0.000464	0.00137	CcSEcCtD
Framycetin—Hypersensitivity—Betaxolol—hypertension	0.000459	0.00136	CcSEcCtD
Framycetin—Pruritus—Perindopril—hypertension	0.000458	0.00136	CcSEcCtD
Framycetin—Pruritus—Irbesartan—hypertension	0.000456	0.00135	CcSEcCtD
Framycetin—Diarrhoea—Captopril—hypertension	0.000456	0.00135	CcSEcCtD
Framycetin—Vomiting—Clonidine—hypertension	0.000455	0.00135	CcSEcCtD
Framycetin—Pruritus—Hydrochlorothiazide—hypertension	0.000453	0.00134	CcSEcCtD
Framycetin—Hypersensitivity—Losartan—hypertension	0.000447	0.00133	CcSEcCtD
Framycetin—Nausea—Valsartan—hypertension	0.000446	0.00132	CcSEcCtD
Framycetin—Pruritus—Furosemide—hypertension	0.000445	0.00132	CcSEcCtD
Framycetin—Nausea—Olmesartan—hypertension	0.000444	0.00132	CcSEcCtD
Framycetin—Vomiting—Trandolapril—hypertension	0.000444	0.00132	CcSEcCtD
Framycetin—Diarrhoea—Perindopril—hypertension	0.000443	0.00131	CcSEcCtD
Framycetin—Vomiting—Enalapril—hypertension	0.000442	0.00131	CcSEcCtD
Framycetin—Diarrhoea—Irbesartan—hypertension	0.000441	0.00131	CcSEcCtD
Framycetin—Pruritus—Betaxolol—hypertension	0.000441	0.00131	CcSEcCtD
Framycetin—Diarrhoea—Hydrochlorothiazide—hypertension	0.000438	0.0013	CcSEcCtD
Framycetin—Vomiting—Telmisartan—hypertension	0.000436	0.00129	CcSEcCtD
Framycetin—Diarrhoea—Furosemide—hypertension	0.00043	0.00128	CcSEcCtD
Framycetin—Pruritus—Losartan—hypertension	0.000429	0.00127	CcSEcCtD
Framycetin—Diarrhoea—Betaxolol—hypertension	0.000426	0.00126	CcSEcCtD
Framycetin—Nausea—Clonidine—hypertension	0.000425	0.00126	CcSEcCtD
Framycetin—Vomiting—Captopril—hypertension	0.000424	0.00126	CcSEcCtD
Framycetin—Diarrhoea—Losartan—hypertension	0.000415	0.00123	CcSEcCtD
Framycetin—Nausea—Trandolapril—hypertension	0.000414	0.00123	CcSEcCtD
Framycetin—Nausea—Enalapril—hypertension	0.000413	0.00122	CcSEcCtD
Framycetin—Vomiting—Perindopril—hypertension	0.000411	0.00122	CcSEcCtD
Framycetin—Vomiting—Irbesartan—hypertension	0.00041	0.00122	CcSEcCtD
Framycetin—Nausea—Telmisartan—hypertension	0.000407	0.00121	CcSEcCtD
Framycetin—Vomiting—Hydrochlorothiazide—hypertension	0.000407	0.00121	CcSEcCtD
Framycetin—Vomiting—Furosemide—hypertension	0.0004	0.00119	CcSEcCtD
Framycetin—Vomiting—Betaxolol—hypertension	0.000396	0.00117	CcSEcCtD
Framycetin—Nausea—Captopril—hypertension	0.000396	0.00117	CcSEcCtD
Framycetin—Vomiting—Losartan—hypertension	0.000386	0.00114	CcSEcCtD
Framycetin—Nausea—Perindopril—hypertension	0.000384	0.00114	CcSEcCtD
Framycetin—Hypersensitivity—Ramipril—hypertension	0.000383	0.00114	CcSEcCtD
Framycetin—Nausea—Irbesartan—hypertension	0.000383	0.00114	CcSEcCtD
Framycetin—Nausea—Hydrochlorothiazide—hypertension	0.00038	0.00113	CcSEcCtD
Framycetin—Hypersensitivity—Timolol—hypertension	0.000375	0.00111	CcSEcCtD
Framycetin—Nausea—Furosemide—hypertension	0.000374	0.00111	CcSEcCtD
Framycetin—Nausea—Betaxolol—hypertension	0.00037	0.0011	CcSEcCtD
Framycetin—Pruritus—Ramipril—hypertension	0.000368	0.00109	CcSEcCtD
Framycetin—Nausea—Losartan—hypertension	0.000361	0.00107	CcSEcCtD
Framycetin—Pruritus—Timolol—hypertension	0.00036	0.00107	CcSEcCtD
Framycetin—Diarrhoea—Ramipril—hypertension	0.000356	0.00106	CcSEcCtD
Framycetin—Diarrhoea—Timolol—hypertension	0.000348	0.00103	CcSEcCtD
Framycetin—Hypersensitivity—Lisinopril—hypertension	0.000348	0.00103	CcSEcCtD
Framycetin—Pruritus—Lisinopril—hypertension	0.000334	0.00099	CcSEcCtD
Framycetin—Vomiting—Ramipril—hypertension	0.000331	0.000981	CcSEcCtD
Framycetin—Vomiting—Timolol—hypertension	0.000324	0.000959	CcSEcCtD
Framycetin—Diarrhoea—Lisinopril—hypertension	0.000323	0.000957	CcSEcCtD
Framycetin—Nausea—Ramipril—hypertension	0.000309	0.000917	CcSEcCtD
Framycetin—Nausea—Timolol—hypertension	0.000302	0.000896	CcSEcCtD
Framycetin—Vomiting—Lisinopril—hypertension	0.0003	0.00089	CcSEcCtD
Framycetin—Nausea—Lisinopril—hypertension	0.00028	0.000831	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GCG—hypertension	0.000186	0.000376	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADRB2—hypertension	0.000185	0.000375	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO1—hypertension	0.000184	0.000373	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AVPR1A—hypertension	0.000184	0.000372	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CYSLTR1—hypertension	0.000184	0.000372	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCE—hypertension	0.000183	0.00037	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LHB—hypertension	0.000182	0.000368	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—VAV3—hypertension	0.000181	0.000365	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GAL—hypertension	0.00018	0.000364	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RGS2—hypertension	0.00018	0.000364	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KNG1—hypertension	0.000178	0.000361	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—UTS2—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNRH1—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CMA1—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VIP—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CRHR1—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TRH—hypertension	0.000178	0.000359	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGTR1—hypertension	0.000177	0.000359	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GNB3—hypertension	0.000176	0.000357	CbGpPWpGaD
Framycetin—CXCR4—Disease—GOT2—hypertension	0.000176	0.000356	CbGpPWpGaD
Framycetin—CXCR4—Disease—CYBA—hypertension	0.000175	0.000354	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AVP—hypertension	0.000174	0.000352	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL10—hypertension	0.000173	0.00035	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OXTR—hypertension	0.000172	0.000348	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GNAS—hypertension	0.000172	0.000347	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CR1—hypertension	0.00017	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TRPC3—hypertension	0.00017	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASR—hypertension	0.00017	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LRP2—hypertension	0.00017	0.000345	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALCA—hypertension	0.000169	0.000343	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADRB2—hypertension	0.000168	0.00034	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HDAC6—hypertension	0.000167	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CX3CL1—hypertension	0.000167	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BDKRB1—hypertension	0.000167	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCE—hypertension	0.000166	0.000336	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—EDN1—hypertension	0.000165	0.000335	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCL5—hypertension	0.000164	0.000332	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—VAV3—hypertension	0.000164	0.000332	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HSPG2—hypertension	0.000164	0.000332	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADRBK1—hypertension	0.000163	0.000331	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDE4D—hypertension	0.000162	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GABBR1—hypertension	0.000162	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTH—hypertension	0.000162	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKG1—hypertension	0.000162	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADM—hypertension	0.000162	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS1—hypertension	0.000161	0.000326	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALM2—hypertension	0.000161	0.000325	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GNB3—hypertension	0.00016	0.000324	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CYBB—hypertension	0.000158	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GLP1R—hypertension	0.000158	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TACR1—hypertension	0.000158	0.00032	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—hypertension	0.000158	0.00032	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AVP—hypertension	0.000158	0.00032	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADCY5—hypertension	0.000157	0.000318	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A4—hypertension	0.000157	0.000317	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCG—hypertension	0.000156	0.000316	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GNAS—hypertension	0.000156	0.000316	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRH3—hypertension	0.000156	0.000315	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCA—hypertension	0.000155	0.000314	CbGpPWpGaD
Framycetin—CXCR4—Disease—KL—hypertension	0.000154	0.000311	CbGpPWpGaD
Framycetin—CXCR4—Disease—GOT1—hypertension	0.000152	0.000307	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EDN1—hypertension	0.00015	0.000304	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRL—hypertension	0.00015	0.000303	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL5—hypertension	0.000149	0.000302	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR5—hypertension	0.000148	0.000299	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCD—hypertension	0.000148	0.000299	CbGpPWpGaD
Framycetin—CXCR4—Disease—HDAC1—hypertension	0.000147	0.000298	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCF2—hypertension	0.000145	0.000293	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—HTR2A—hypertension	0.000145	0.000293	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—C3—hypertension	0.000145	0.000293	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADCY5—hypertension	0.000143	0.000289	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCG—hypertension	0.000142	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NPY—hypertension	0.000141	0.000286	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VWF—hypertension	0.000141	0.000286	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCA—hypertension	0.000141	0.000285	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCE—hypertension	0.00014	0.000283	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFA—hypertension	0.000138	0.00028	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AGT—hypertension	0.000137	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFBR2—hypertension	0.000136	0.000276	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL2—hypertension	0.000136	0.000276	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR2—hypertension	0.000136	0.000276	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR1B—hypertension	0.000136	0.000276	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OXT—hypertension	0.000136	0.000276	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—F2R—hypertension	0.000135	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFBR1—hypertension	0.000135	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCD—hypertension	0.000134	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR5—hypertension	0.000134	0.000272	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HTR2A—hypertension	0.000131	0.000266	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—C3—hypertension	0.000131	0.000266	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NCF1—hypertension	0.00013	0.000264	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDNRB—hypertension	0.00013	0.000264	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TAC1—hypertension	0.000129	0.000261	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOB—hypertension	0.000129	0.000261	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PRKCB—hypertension	0.000127	0.000257	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—F2—hypertension	0.000127	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCR3—hypertension	0.000127	0.000256	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ANXA1—hypertension	0.000127	0.000256	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IKBKB—hypertension	0.000125	0.000254	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AGT—hypertension	0.000125	0.000252	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDNRA—hypertension	0.000123	0.000249	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SST—hypertension	0.000123	0.000249	CbGpPWpGaD
Framycetin—CXCR4—Disease—LPL—hypertension	0.000123	0.000249	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CALM1—hypertension	0.000123	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRB1—hypertension	0.000123	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DRD3—hypertension	0.000123	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CYBA—hypertension	0.000123	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FLT1—hypertension	0.000123	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Disease—H2AFX—hypertension	0.000122	0.000247	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFRB—hypertension	0.000122	0.000247	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRA2A—hypertension	0.000121	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADCY5—hypertension	0.00012	0.000244	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLAT—hypertension	0.00012	0.000243	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GHRL—hypertension	0.00012	0.000243	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCG—hypertension	0.00012	0.000242	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCA—hypertension	0.000119	0.00024	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALCA—hypertension	0.000119	0.00024	CbGpPWpGaD
Framycetin—CXCR4—Disease—YWHAZ—hypertension	0.000118	0.000238	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BDKRB2—hypertension	0.000116	0.000234	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—POMC—hypertension	0.000116	0.000234	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—F2—hypertension	0.000115	0.000233	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PRKCB—hypertension	0.000115	0.000233	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRBK1—hypertension	0.000114	0.000232	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR1—hypertension	0.000114	0.00023	CbGpPWpGaD
Framycetin—CXCR4—Disease—PRKCD—hypertension	0.000113	0.000229	CbGpPWpGaD
Framycetin—CXCR4—Disease—CCR5—hypertension	0.000113	0.000229	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALM2—hypertension	0.000112	0.000228	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT2—hypertension	0.000111	0.000225	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DRD2—hypertension	0.000111	0.000224	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR7—hypertension	0.000111	0.000224	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—hypertension	0.000111	0.000224	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GCG—hypertension	0.00011	0.000222	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTPN1—hypertension	0.00011	0.000222	CbGpPWpGaD
Framycetin—CXCR4—Disease—PDGFB—hypertension	0.000108	0.000218	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KL—hypertension	0.000108	0.000218	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH2—hypertension	0.000108	0.000218	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR1—hypertension	0.000107	0.000217	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITGAV—hypertension	0.000106	0.000214	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGFR—hypertension	0.000106	0.000214	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—hypertension	0.000106	0.000214	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KNG1—hypertension	0.000105	0.000213	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—hypertension	0.000105	0.000212	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRL—hypertension	0.000105	0.000212	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGTR1—hypertension	0.000105	0.000212	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALM1—hypertension	0.000103	0.000209	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HDAC1—hypertension	0.000103	0.000209	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STK11—hypertension	0.000103	0.000209	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOE—hypertension	0.000103	0.000209	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL2—hypertension	0.000103	0.000208	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL10—hypertension	0.000102	0.000207	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—hypertension	0.000102	0.000207	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PLG—hypertension	0.000102	0.000206	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA1—hypertension	0.000102	0.000206	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—RHOA—hypertension	0.000102	0.000206	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT2—hypertension	0.000101	0.000204	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3R1—hypertension	0.000101	0.000204	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADRB2—hypertension	9.93e-05	0.000201	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCE—hypertension	9.81e-05	0.000198	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VAV3—hypertension	9.69e-05	0.000196	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFA—hypertension	9.69e-05	0.000196	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS2—hypertension	9.61e-05	0.000194	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFBR2—hypertension	9.55e-05	0.000193	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOTCH1—hypertension	9.51e-05	0.000193	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNB3—hypertension	9.46e-05	0.000191	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AVP—hypertension	9.33e-05	0.000189	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RHOA—hypertension	9.25e-05	0.000187	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNAS—hypertension	9.21e-05	0.000186	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3R1—hypertension	9.16e-05	0.000185	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOB—hypertension	9.02e-05	0.000183	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTK2—hypertension	8.98e-05	0.000182	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—hypertension	8.94e-05	0.000181	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EDN1—hypertension	8.88e-05	0.00018	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL5—hypertension	8.81e-05	0.000178	CbGpPWpGaD
Framycetin—CXCR4—Disease—INS—hypertension	8.81e-05	0.000178	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LPL—hypertension	8.61e-05	0.000174	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—H2AFX—hypertension	8.55e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFRB—hypertension	8.54e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RPS6KB1—hypertension	8.54e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT2—hypertension	8.51e-05	0.000172	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADCY5—hypertension	8.43e-05	0.000171	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCG—hypertension	8.37e-05	0.000169	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ITGB3—hypertension	8.32e-05	0.000168	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCA—hypertension	8.32e-05	0.000168	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—YWHAZ—hypertension	8.25e-05	0.000167	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—hypertension	8.16e-05	0.000165	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NGF—hypertension	8.16e-05	0.000165	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—hypertension	8.12e-05	0.000164	CbGpPWpGaD
Framycetin—CXCR4—Disease—SERPINE1—hypertension	8.09e-05	0.000164	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR5—hypertension	7.94e-05	0.000161	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCD—hypertension	7.94e-05	0.000161	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF2—hypertension	7.83e-05	0.000158	CbGpPWpGaD
Framycetin—CXCR4—Disease—RHOA—hypertension	7.8e-05	0.000158	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HTR2A—hypertension	7.77e-05	0.000157	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—C3—hypertension	7.76e-05	0.000157	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3R1—hypertension	7.72e-05	0.000156	CbGpPWpGaD
Framycetin—CXCR4—Disease—NOS3—hypertension	7.72e-05	0.000156	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PDGFB—hypertension	7.55e-05	0.000153	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR1—hypertension	7.51e-05	0.000152	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—hypertension	7.4e-05	0.00015	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AGT—hypertension	7.37e-05	0.000149	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALM1—hypertension	7.25e-05	0.000147	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—hypertension	7.22e-05	0.000146	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOE—hypertension	7.22e-05	0.000146	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—hypertension	7.15e-05	0.000145	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOA1—hypertension	7.14e-05	0.000144	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—hypertension	7.13e-05	0.000144	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—hypertension	7.07e-05	0.000143	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—hypertension	7.06e-05	0.000143	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PRKCB—hypertension	6.81e-05	0.000138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—F2—hypertension	6.81e-05	0.000138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FN1—hypertension	6.81e-05	0.000138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH1—hypertension	6.66e-05	0.000135	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—hypertension	6.2e-05	0.000125	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—hypertension	6.17e-05	0.000125	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—INS—hypertension	6.17e-05	0.000125	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—hypertension	6.16e-05	0.000125	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL2—hypertension	6.07e-05	0.000123	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—hypertension	5.97e-05	0.000121	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT2—hypertension	5.96e-05	0.000121	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—hypertension	5.94e-05	0.00012	CbGpPWpGaD
Framycetin—CXCR4—Disease—EP300—hypertension	5.88e-05	0.000119	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—hypertension	5.71e-05	0.000116	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SERPINE1—hypertension	5.67e-05	0.000115	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF2—hypertension	5.48e-05	0.000111	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RHOA—hypertension	5.47e-05	0.000111	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOS3—hypertension	5.41e-05	0.000109	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3R1—hypertension	5.41e-05	0.000109	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—hypertension	5.12e-05	0.000104	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—hypertension	5.11e-05	0.000103	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RELA—hypertension	5.09e-05	0.000103	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—hypertension	5.01e-05	0.000101	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—hypertension	4.99e-05	0.000101	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—hypertension	4.8e-05	9.71e-05	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—hypertension	4.63e-05	9.38e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—hypertension	4.56e-05	9.23e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—hypertension	4.34e-05	8.78e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—hypertension	4.32e-05	8.75e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—hypertension	4.31e-05	8.73e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK8—hypertension	4.22e-05	8.54e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—hypertension	4.21e-05	8.52e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EP300—hypertension	4.11e-05	8.33e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—hypertension	4e-05	8.1e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—hypertension	3.9e-05	7.88e-05	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—hypertension	3.85e-05	7.79e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—hypertension	3.59e-05	7.25e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—hypertension	3.58e-05	7.24e-05	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—hypertension	3.55e-05	7.18e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—hypertension	3.51e-05	7.1e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—hypertension	2.94e-05	5.96e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—hypertension	2.7e-05	5.45e-05	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—hypertension	2.49e-05	5.03e-05	CbGpPWpGaD
